Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1942506Generated: November 3, 2026

Diisopropylethylamine → tert-Butyl (3R)-3-[{[2,2-dimethyl-3-oxo-7-(trifluoromethyl)-4-(2-{[1-(trifluoromethyl)propyl]amino}-ethyl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]carbonyl}(isopropyl)amino]piperidine-1-carboxylate

https://huagongshe.com/reaction/1942506

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
Reactant1,1,1-Trifluorobutan-2-oneHCID 238288—
ReactantSodium BicarbonateHCID 516892—
ReactantSodium cyanoborohydrideHCID 5003444—
Reactanttert-butyl (3R)-3-[{[4-(2-aminoethyl)-2,2-dimethyl-3-oxo-7-(trifluoromethyl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]carbonyl}(isopropyl)amino]piperidine-1-carboxylateHCID 58376011—
CatalystTitanium TetrachlorideHCID 24193—
SolventMethanolHCID 887—
SolventDichloromethaneHCID 6344—
Producttert-Butyl (3R)-3-[{[2,2-dimethyl-3-oxo-7-(trifluoromethyl)-4-(2-{[1-(trifluoromethyl)propyl]amino}-ethyl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]carbonyl}(isopropyl)amino]piperidine-1-carboxylateHCID 86656360—

Reaction Steps

To a solution of tert-butyl (3R)-3-[{[4-(2-aminoethyl)-2,2-dimethyl-3-oxo-7-(trifluoromethyl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]carbonyl}(isopropyl)amino]piperidine-1-carboxylate (278 mg) in methylene chloride (2 ml) were added 1,1,1-trifluoro-2-butanone (0.1 ml), diisopropylethylamine (0.34 ml), and titanium tetrachloride (0.05 ml), and the mixture was stirred at room temperature for 3 hours. Then, to the reaction solution were added sodium cyanoborohydride (110 mg) and methanol (10 ml), and the mixture was stirred at room temperature for one hour. To the reaction solution was added a saturated aqueous sodium hydrogen carbonate solution (10 ml), and the mixture was extracted with ethyl acetate. The organic layer was dried over magnesium sulfate, filtered, and concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (hexane/ethyl acetate=3:1) to give the title compound (100 mg) as amorphous.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08389511B2
Source datasetuspto-grants-2013_03
ORD IDord-2949c7852da243de81dab663d1fcfc30
Source noteuspto-grants-2013_03